These collective findings establish the dual role of FASN in suppressing apoptosis and promoting angiogenesis across multiple cancer types, thereby substantiating our hypothesis that FASN acts as the mechanistic executor through which the circHIPK3/ALYREF axis drives oncogenic effects in GBC. Here, ALYREF is linked to cancer.